Clinical Trial: A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy(R) (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018544) titled 'A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy(R) (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea' on June 04.

Brief Summary: This study is conducted to investigate the safety and effectiveness of semaglutide in participants with obesity and overweight in routine clinical practice. Participants will get semaglutide as prescribed by a doctor. This study will last for about 4 years and participants will participate in the study for approximately 26 weeks.

Study...